Search
× Search

Pollen Seasons

Trees in Central Oklahoma trees begin pollinating from mid-September (mountain cedar from the Arbuckle Mountains) through early May (pecan) and late June (pine). There is a second elm season in the fall (late August to October) due to the introduction of lacebark elms and cedar elms to this area. Each of the common tree species (elm, oak, maple/box elder, pecan/hickory, birch, mulberry, juniper, sycamore, pine, cottonwood/poplar, willow) usually pollinate for only a few weeks but added together the season is quite long.

Grasses

Central Oklahoma has two grass seasons. Cool season grasses (blue, fescue, timothy, rye, orchard, and redtop) can begin as early as late February or March but after a month or two they stop pollinating totally. The warm season grasses (which do not cross-react with cool season grasses) such as Bermuda, Bahia, crabgrass, and Johnson begin when the weather becomes warm and do not always stop until a good hard freeze in November.

Weeds

Some weeds pollinate in late spring or summer (dock and plantain), but most begin in late summer and fall. Ragweed pollination begins based on hours of daylight and almost always begin when the days shorten around the middle of August. However, the weeds often continue to pollinate until there is a hard freeze, often in late November.

Molds

We find molds in Central Oklahoma every day of the year unless there is a very hard freeze and/or the ground is covered with snow.
The Oklahoma Allergy & Asthma Clinic is a certified counting station for pollen and mold. We are associated with the National Allergy Bureau and the AAAAI. You can find our counts on the internet at www.oklahomaallergy.com. We supply the local media (TV stations, newspaper and radio) with our counts every day they are done. To learn more about the National Allergy Bureau (NAB) you can go to www.aaaai.org.

Recent News

FDA Alerts of Perrigo’s voluntary albuterol inhaler recall
SuperUser Account
/ Categories: News

FDA Alerts of Perrigo’s voluntary albuterol inhaler recall

The U.S. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of all unexpired albuterol sulfate inhalation aerosol manufactured by Catalent Pharma Solutions for Perrigo Pharmaceutical Company in Minneapolis, due to possible clogging of the inhaler resulting in patients not receiving enough or any medicine. This recall is to the retail level. FDA urges patients to continue using the inhaler they have on hand.

The albuterol inhaler delivers medication into the body through the airway and lungs, where it opens the airways to treat asthma and other conditions, such as chronic obstructive pulmonary disease (COPD). Patients could face health risks if their rescue albuterol inhaler malfunctions and does not relieve symptoms in an emergency situation. FDA advises patients to:

  • immediately seek emergency care if needed;
  • use their Perrigo inhaler they have on hand, as needed and as directed by a doctor;
  • have extra inhalers or an alternative treatment available in case of malfunction, as some of these recalled inhalers stop working after several uses; and
  • contact their health care professional or pharmacist with questions.

FDA reminds health care professionals and patients that albuterol inhalers are available through additional manufacturers.

Perrigo informed FDA it has received several thousand complaints about its product. Most of the complaints were for clogging and failure to dispense enough medicine. The manufacturer of Perrigo’s albuterol inhaler, Catalent, stopped producing and distributing the albuterol inhaler products on August 21, 2020, and is currently investigating the malfunction.

The agency asks health care professionals and patients to report unexpected side effects or quality problems associated with albuterol inhalers to FDA’s MedWatch Adverse Event Reporting program:

Complete and submit the report online at www.fda.gov/medwatch/report.htm; or

Download and complete the form, then submit it via fax at 1-800-FDA-0178.

 

The post FDA Alerts of Perrigo’s voluntary albuterol inhaler recall appeared first on Oklahoma Allergy and Asthma Clinic.

Previous Article The Science of Masks – featuring Dr. Laura Chong, OAAC Allergist
Next Article Fall 2020 The Allergist Newsletter
Print
14
Terms Of UsePrivacy StatementCopyright 2026 by Oklahoma Allergy and Asthma Clinic
Back To Top